Plasma-Derived Factor VIII Has No Immunogenic Advantage (CME/CE)
(MedPage Today) -- Factor VIII clotting factors derived from donor plasma were just as likely as recombinant products to induce inhibitory antibodies in children with hemophilia A, researchers said.
Tags:
Plasma-Derived Factor VIII Has No Immunogenic Advantage (CME/CE),
Children Latest News